Delivery Order SPE2DB25D3404-SPE2DB25FUPUH
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Armodafinil 250 mg tablets in quantities of 30 units, with a ceiling value of $1,196.97. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 8, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,779.24 to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count units) under a firm fixed-price contract with a ceiling value of $1,672.50. The contract was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, and involves no set-aside designation. Performance will be conducted at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,789.78 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count units) on July 29, 2025, with a completion date of July 30, 2025. This firm fixed price delivery order represents a non-set-aside, competitively awarded contract with performance at the vendor's Conshohocken, Pennsylvania facility. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,115.00 to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count packages) on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed price, non-set-aside contract will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Armodafinil 250mg (30-count packages) with a ceiling value of $1,696.10. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract is scheduled for ultimate completion on July 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,566.44 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count units) under a firm fixed-price contract. The delivery order was awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award utilizes no set-aside designation and was competitively awarded. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Armodafinil 250 mg tablets (30-count packages) under a firm fixed-price contract valued at $3,655.82, with completion scheduled for July 29, 2025. This non-set-aside competitive award was issued on July 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Armodafinil is a wakefulness-promoting agent commonly used to treat narcolepsy, obstructive...
- The Defense Logistics Agency awarded a $5,557.23 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Armodafinil 250 mg tablets in quantities of 30. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. This delivery order is issued as a child...
- The Defense Logistics Agency Troop Support Medical awarded a $2,250 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 250mg armodafinil tablets. Under this contract, Amerisourcebergen will deliver 30 tablets of armodafinil to a location in Conshohocken, Pennsylvania. The delivery order was awarded on July 25, 2023 and has a period of performance concluding on July 26, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB25FUPUHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,199.45 to AmerisourceBergen Drug Corp for the supply of Armodafinil 250 mg tablets (30-count units) on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, one of the nation's leading pharmaceutical distributors, fulfills critical medical procurement needs for military and veteran healthcare systems through its comprehensive portfolio of pharmaceutical products and medical supplies. The SPE2DX indefinite delivery vehicle serves as a global pharmaceutical support mechanism enabling the company to supply brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. This particular delivery order for Armodafinil, a wakefulness-promoting agent commonly used in military and federal healthcare settings, exemplifies the routine pharmaceutical fulfillment operations conducted under this expansive contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 8/13/25 |